Icahn Drops Amylin Suit After Talks With CEO Bradbury

Billionaire Carl Icahn dropped a lawsuit against Amylin Pharmaceuticals Inc. over a corporate bylaw that blocked investors from ousting directors who rejected a Bristol-Myers Squibb Co. takeover offer.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.